Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Proof of concept trial of LPCN-1144

Next Previous
Trial Profile

A Proof of concept trial of LPCN-1144

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Jan 2019

At a glance

  • Drugs LPCN-1144 (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Acronyms Liver Fat Study

    • Most Recent Events

    • 17 Jan 2019 According to a Lipocine media release, sixteen-week results from the study are expected later this quarter.
    • 17 Jan 2019 Eight-week top-line interim results presented in a Lipocine media release.
    • 05 Nov 2018 According to a Lipocine media release, results from this trial are expected in the first quarter of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top